Navigation Links
AAAS decries latest stem cell veto

The President has again vetoed the Stem Cell Research Enhancement Act, which would expand federal support for embryonic stem cell research. AAAS, the world’s largest general scientific society, stands with a broad coalition of Americans spanning all parties and faiths that supports this bill.

The scientific consensus is that embryonic stem cell research is an extremely promising approach to developing more effective treatments for devastating conditions like diabetes, spinal cord injuries, and Parkinson’s disease. The bill would mandate that such research be allowed to compete for federal funding while following strict ethical guidelines.

The Executive Order is not a substitute for the Stem Cell Research Enhancement Act. The new approaches addressed by the order are still in the early stages of development and appear to already be eligible for NIH funding. AAAS strongly believes that it is only through federal support of diverse avenues of stem cell research that we may better understand the potential value and limitations of each approach.

During his tenure the President has acknowledged that it is a critical time for the American scientific enterprise, therefore it is disappointing that he has chosen to maintain restrictions on such a promising area of research. AAAS will continue to support the interests of scientists and patients in fostering medical progress. The American Association for the Advancement of Science (AAAS) on Wednesday expressed disappointment with the decision by President George W. Bush to veto a landmark stem cell research funding bill.

The measure would have lifted restrictions on federal funding of medical research using embryonic stem cells, which proponents say would be derived from microscopic embryos left over and due to be discarded after in vitro fertility treatments. Current U.S. policy limits such funding to fewer than 20 stem cell lines that had been created when the president first announce
'"/>

Source:American Association for the Advancement of Science


Page: 1 2 3

Related biology news :

1. NHGRI announces latest sequencing targets

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AAAS decries latest stem cell veto

(Date:11/9/2009)...nia and elsewhere provide support for the use of m...d protecting marine habitats, according to biologi..., A recent study in the Gulf of California, for ...ehind marine reserves--the idea that offspring pro... of harvested species outside the reserve. , "It...
(Date:11/9/2009)...ad their hands tied because more than half of all ...n called p53. As a critical anti-cancer watchdog, ... within cells. When cells lose p53, tumors grow ag... tumors might be tough, but they,re not invincible...oratory (CSHL). The chink in the tumors, armor, ac...
(Date:11/9/2009)...researchers has completed a first draft of the cas... important first step in accelerating the pace of ...ome of the many limitations that face cassava farm...hat serves as the primary food source for more tha...y properties that make it an important food across...
Breaking Biology News(10 mins):Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 1Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 2Nurses File Cal OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients 51699 3HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 51697 1HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 51697 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 1YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 3
...OZEMAN -- The U.S. Department of Energy on Monday ...tration Partnership at Montana State University to... carbon dioxide into the sandstone rock layer bene...hird and final phase of federal funding for the Bi...ately $14 million of the federal money will stay o...
...ovember 17, 2008 (Bronx, NY) A team of researche...lege of Medicine of Yeshiva University has determi...ay have the unintended consequence of increasing t...inding could alter the way doctors prescribe migra... the journal Headache , the Einstein-led study of...
...Two new compounds created by a University of Centr...ying breast cancer tumors. , Associate Professor ...d spread of breast cancer tumors in tests on mice.... cancer-causing protein called STAT3, and research... , "The compounds are very promising," Turkson sa...
Other Biology News:Montana State partnership receives $66.9M for carbon sequestration 2Montana State partnership receives $66.9M for carbon sequestration 3Overuse of narcotics and barbiturates may make migraine worse 2Two new compounds show promise for eliminating breast cancer tumors 2
(Date:11/9/2009)...SHINGTON, Nov. 9 The Ap...n Humanist Association, held a panel discussion to...rsial emerging technologies in biomedical sciences...athan Moreno and Andrew Light, both of the Center ...rom ethical and political angles. ,, A video o...
(Date:11/9/2009)... SHANGHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma...ir evolution. The companies are facing significan...ocketing R&D costs, calls for,lower prices and...ether with,the financial crisis have made the work...aceutical companies are being forced to globalize ...
(Date:11/9/2009)... LONDON, November 9 Following the...US Food and Drug Administration (FDA), privately,o...://www.davalinternational.com ) has been informed ...O(R) has been awarded an Orphan-Drug,designation f...(ALS). , ALS, also known as Lou Gehrig,s ...
(Date:11/6/2009)...NBROOK, N.Y., Nov. 6 Bio...iopharmaceutical company developing first-in-class...inancial results for the third quarter ended Septe...t, in September of this year, the FDA,s Arthritis ...ote of 12-0, the approval of XIAFLEX(TM) for the t...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...IX, Nov. 6 NutraCea (OTC Bulletin Board:,NTRZ), a...ent research and,technology announced today that i...position of Chief Financial Officer. Todd Crow, in...ns, has retired as CFO, but will remain,available ...ndez-Longan has over 20 years of financial experie...
...rd quarter net loss narrows on higher revenue due ...nterMune, Inc.,(Nasdaq: ITMN ) today announced re...ne months ended September 30, 2008. InterMune repo...12.5 million, or $0.32 per share,compared with a n...he third,quarter of 2007., Dan Welch, Chairman, C...
..., Pa., Nov. 6 ViroPharma Incorporated,(Nasdaq: V...nt and chief,executive officer of ViroPharma, will...estment Conference at 12:25 P.M. ET on Wednesday, ... the New York Palace Hotel., ViroPharma also anno...ntific officer of ViroPharma will present at the L...
Other Biology Technology:NutraCea Appoints New Chief Financial Officer 2InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 2InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 3InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 4InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 5InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 6InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 7InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 8InterMune Reports Third Quarter 2008 Financial Results and Business Highlights 9ViroPharma to Present at Three November Healthcare Conferences 2
ChemiArray Mouse Lysate Cytokine Antibody Array III, 62 cytokines per membrane from CHEMICON
50 ml Magnetic Separation Rack from New England Biolabs
ChIP-GLAS-H10K-B from Aviva Systems Biology
TOPO Shotgun Subcloning Kit from Invitrogen
Biology Products: